Reinventing Heart Drug Discovery with AI and Omics Cardiovascular disease (CVD) remains the world’s leading cause of death, despite decades of medical advances. A new perspective from Brigham and Women’s Hospital and Harvard Medical School argues that the future of heart drug development lies in an integrated, data-driven framework. By combining artificial intelligence (AI), omics…